{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:18Z","timestamp":1786119258647,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6,27]]},"DOI":"10.1097\/tp.0b013e3181a75ad2","type":"journal-article","created":{"date-parts":[[2009,6,17]],"date-time":"2009-06-17T03:21:51Z","timestamp":1245208911000},"page":"1852-1857","source":"Crossref","is-referenced-by-count":69,"title":["Experience With Immune Monitoring in Lung Transplant Recipients: Correlation of Low Immune Function With Infection"],"prefix":"10.1097","volume":"87","author":[{"given":"Shahid","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Pilewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Zaldonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshi","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Shutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Spichty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Bentlejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Pakstis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"McCurry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210211","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-0012.2003.00013.x","article-title":"Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management.","volume":"17","author":"Kowalski","year":"2003","journal-title":"Clin Transplant"},{"key":"R2-15-20210211","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.qco.0000136933.67920.dd","article-title":"Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients.","volume":"17","author":"Pereyra","year":"2004","journal-title":"Curr Opin Infect Dis"},{"issue":"suppl 1","key":"R3-15-20210211","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/320896","article-title":"Introduction to the Immunocompromised Host Society consensus conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients.","volume":"33","author":"Rubin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R4-15-20210211","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1399-3062.1999.10103.x","article-title":"Infection in solid organ transplantation.","volume":"1","author":"Snydman","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"R5-15-20210211","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00042307-200203000-00007","article-title":"Urinary tract infections after renal transplantation.","volume":"12","author":"Schmaldienst","year":"2002","journal-title":"Curr Opin Urol"},{"key":"R6-15-20210211","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-0012.2003.00013.x","article-title":"Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management.","volume":"17","author":"Kowalski","year":"2003","journal-title":"Clin Transplant"},{"key":"R7-15-20210211","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jtcvs.2004.09.040","article-title":"Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.","volume":"130","author":"McCurry","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R8-15-20210211","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/01.tp.0000263992.41003.33","article-title":"Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.","volume":"83","author":"Husain","year":"2007","journal-title":"Transplantation"},{"key":"R9-15-20210211","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation.","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"key":"R10-15-20210211","first-page":"1","article-title":"Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group.","volume":"15","author":"Yousem","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"R11-15-20210211","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-0012.2003.00013.x","article-title":"Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management.","volume":"17","author":"Kowalski","year":"2003","journal-title":"Clin Transplant"},{"key":"R12-15-20210211","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MCP.0b013e3282f9b1d1","article-title":"Fungal infections in lung transplant recipients.","volume":"14","author":"Silveira","year":"2008","journal-title":"Curr Opin Pulm Med"},{"key":"R13-15-20210211","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/510388","article-title":"Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.","volume":"44","author":"Peleg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R14-15-20210211","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jpedsurg.2008.02.044","article-title":"Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.","volume":"43","author":"Sampson","year":"2008","journal-title":"J Pediatr Surg"},{"key":"R15-15-20210211","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1097\/01.tp.0000243358.75863.57","article-title":"Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies.","volume":"82","author":"Sommerer","year":"2006","journal-title":"Transplantation"},{"key":"R16-15-20210211","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/01.tp.0000250655.14026.5c","article-title":"Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection.","volume":"82","author":"Thai","year":"2006","journal-title":"Transplantation"},{"key":"R17-15-20210211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.trim.2005.03.019","article-title":"Monitoring immune function during tacrolimus tapering in small bowel transplant recipients.","volume":"15","author":"Zeevi","year":"2005","journal-title":"Transpl Immunol"},{"key":"R18-15-20210211","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.healun.2008.05.014","article-title":"Utility of the cylex assay in cardiac transplant recipients.","volume":"27","author":"Gupta","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R19-15-20210211","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.healun.2008.06.005","article-title":"Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.","volume":"27","author":"Bhorade","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R20-15-20210211","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-6143.2006.01641.x","article-title":"Recovery of functional memory T cells in lung transplant recipients following induction therapy with alemtuzumab.","volume":"7","author":"Zeevi","year":"2007","journal-title":"Am J Transplant"},{"key":"R21-15-20210211","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-6143.2007.02078.x","article-title":"Homeostatic repopulation by CD28\u2212CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression.","volume":"8","author":"Trzonkowski","year":"2008","journal-title":"Am J Transplant"},{"key":"R22-15-20210211","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2006.01548.x","article-title":"Voriconazole prophylaxis in lung transplant recipients.","volume":"6","author":"Husain","year":"2006","journal-title":"Am J Transplant"},{"key":"R23-15-20210211","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1086\/421957","article-title":"Antifungal prophylaxis in solid organ transplant recipients: Considerations for clinical trial design.","volume":"39","author":"Singh","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R24-15-20210211","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1399-3062.2002.t01-2-02002.x","article-title":"The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.","volume":"4","author":"Minari","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"R25-15-20210211","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-3062.2006.00156.x","article-title":"Variation in antifungal prophylaxis strategies in lung transplantation.","volume":"8","author":"Husain","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"R26-15-20210211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09629359990496","article-title":"Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.","volume":"8","author":"Pukhalsky","year":"1999","journal-title":"Mediators Inflamm"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-200906270-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:51:09Z","timestamp":1786038669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200906270-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,27]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181a75ad2","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6,27]]}}}